JESSICA HUSEMAN: Open Payments
NPI 1750754735 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $296 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $64 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| HARMONY BIOSCIENCES LLC | 1 | $34 |
| Viatris Specialty LLC | 1 | $26 |
| GENZYME CORPORATION | 1 | $22 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
Products named: NUCALA, WAKIX, YUPELRI, DUPIXENT, ZERBAXA, WINREVAIR, LUMRYZ, Sunosi.
Industry payments across PA — which companies pay providers there.
